Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Nhs National Transition Framework For Apremilast, Pazopanib And Dapagliflozin

NHS England United Kingdom has Released a tender for Nhs National Transition Framework For Apremilast, Pazopanib And Dapagliflozin in Pharmaceuticals. The tender was released on Sep 04, 2025.

Country - United Kingdom

Summary - Nhs National Transition Framework For Apremilast, Pazopanib And Dapagliflozin

Deadline - Sep 03, 2026

GT reference number - 117113191

Product classification - Pharmaceutical products

Organization Details:

  Address - United Kingdom

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 117113191

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026Offer reference number: CM/TNS/25/5735Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.Potential periods of call-offs under the framework agreement:CM/TNS/25/5735 Apremilast, Pazopanib and DapagliflozinLot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS Engla

Gt Ref Id - 117113191

Deadline - Sep 03, 2026

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database